Enquiry/Quote
Ramipril / Hydrochlorothiazide Tablets bulk supplier for pharma manufacturers

Ramipril / Hydrochlorothiazide Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 2.5mg+12.5mg, 5mg+25mg

Reference Brands: Tritazide ((EU), Ramace H (India)

Category: Heart Disorder

The salt combination Ramipril and Hydrochlorothiazide is used for the treatment of High Blood Pressure, Heart Failure, Blood Pressure, Fluid Retention, Liver Failure, Kidney Failure and other conditions. Ramipril / Hydrochlorothiazide Tablets is available in Tablets and strengths such as 2.5mg+12.5mg, 5mg+25mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ramipril / Hydrochlorothiazide Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Ramipril / Hydrochlorothiazide Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Ramipril and Hydrochlorothiazide is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms: · High Blood Pressure · Heart Failure · Blood Pressure · Fluid Retention · Liver Failure · Kidney Failure · Kidney Disorder

Ramipril / Hydrochlorothiazide is a fixed-dose combination (FDC) of an ACE inhibitor and a thiazide diuretic, widely used for the management of hypertension. Marketed under brand names such as Ramace H, Tritace H, and Altace HCT, this combination helps achieve better blood pressure control in patients who require dual therapy.

Ramipril works by inhibiting the angiotensin-converting enzyme (ACE), which reduces the production of angiotensin II, a hormone that narrows blood vessels. This leads to vasodilation and decreased blood pressure. Hydrochlorothiazide is a thiazide diuretic that increases the excretion of sodium and water via the kidneys, reducing blood volume and further contributing to blood pressure reduction.

This combination is indicated for patients whose blood pressure is not adequately controlled with monotherapy. By targeting complementary mechanisms—vascular relaxation and fluid reduction—Ramipril / Hydrochlorothiazide effectively lowers blood pressure, reduces the workload on the heart, and decreases the risk of cardiovascular events such as heart attack and stroke. The medication is administered orally and is available in various strengths to suit individualized treatment needs, making it a cornerstone therapy in hypertension management.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Ramipril / Hydrochlorothiazide is used to treat hypertension (high blood pressure) in patients who require combination therapy. It helps lower blood pressure, reducing the risk of heart attack, stroke, and other cardiovascular complications.

It is a combination of Ramipril, an ACE inhibitor that blocks the formation of angiotensin II to relax blood vessels, and Hydrochlorothiazide, a thiazide diuretic that increases the excretion of sodium and water through the kidneys, lowering blood volume and blood pressure.

This combination is marketed under various trade names depending on the manufacturer and region.

Several pharmaceutical companies manufacture this combination globally, including Sun Pharma, Cipla, and Torrent Pharmaceuticals.

The generic name is Ramipril + Hydrochlorothiazide.

Brand names vary by region and manufacturer, including Ramace H, Tritace H, and other regional brands.

It is manufactured globally, particularly in India, Europe, and other regions, by multiple pharmaceutical companies under approved regulatory standards.

Yes, Ramipril / Hydrochlorothiazide Tablets is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Ramipril / Hydrochlorothiazide Tablets is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Trandolapril

Strength:
0.5 mg, 1 mg, 2 mg

Form: Tablets

Reference Brands: Mavik (USA), Gopten (EU)

View Details
Tirofiban Hydrochloride

Strength:
2.5 mg/mL

Form: Injection

Reference Brands: Aggrastat (USA)

View Details
Selexipag

Strength:
200 mcg, 400 mcg, 600 mcg, 800 mcg, 1000 mcg, 1200 mcg, 1400 mcg, 1600 mcg

Form: Tablets / Injection

Reference Brands: Uptravi (USA/EU)

View Details
Edoxaban

Strength:
15 mg, 30 mg, 60 mg

Form: Tablets

Reference Brands: Savaysa (USA), Lixiana (EU)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.